Ticker HubNasdaq

NXL

Nexalin Technology, Inc. Common Stock

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Latest price

$1.90+2.15%

As of Oct 26, 2026, 5:40 PM EDT · Market data by Massive

Market cap

$2.0M

Volume

51.8K

Previous close

$1.86

Day range

$1.65 – $1.89

Listed

Sep 16, 2022

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $2.36Latest interval $1.90

Newsroom

Latest NXL coverage

Oct 1, 2026

Midday Movers: NXL, SDEV, VEEA Lead the Small-Cap Scan

NXL led a group of 10 active small-cap stocks flagged for editorial review.

NXLSDEVVEEALONA

Company overview

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees: 8
Headquarters: HOUSTON, TX
CIK: 0001527352

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

Sep 16, 2022

Listed

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.